The FDA has accepted Gilead Sciences’ new drug application for lenacapavir as a long-lasting injectable to prevent HIV ...

Legal challenges have restored funding but damage has been done A US-funded health facility in Pretoria shut its doors for over two weeks after an executive order by President Trump paused funding. A ...

Some 400 calls for help went unanswered when the helpline at Ukraine’s Veteran Hub went silent for a week after key funding ...

Dallas, filed a bill this legislative session to prohibit insurance companies from requiring prior authorization before covering medications intended to prevent the ...

State Sen. Scott Wiener and Assemblymember Matt Haney introduced legislation on Thursday that would protect the ...

But now, that progress is at risk. The recent pause in United States foreign assistance poses a direct threat to the lives ...

Starting treatment early for HIV can help you live a healthy life. If you have HIV, you can be treated with antiretroviral medications as part of antiretroviral therapy. These medications: lower the ...

A change in Medicare policy is expected to flatten revenue from Gilead Science's HIV products, one of its most profitable segments.

HIV affects not only your physical health but also your mental health. We reviewed online support groups for the disease, so ...

Gilead Sciences is rated a Strong Buy due to strong Q4 2024 results and a robust HIV franchise. Check out my 12-month price ...

Biogen expects Leqembi and new rare disease and depression treatments to help offset revenue lost from multiple sclerosis ...

The chaos and uncertainty surrounding vital AIDS relief programs have needlessly threatened millions of lives, writes Drs.